I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 13 studies | 25% ± 7% | |
| mast cell | 12 studies | 25% ± 9% | |
| fibroblast | 12 studies | 21% ± 5% | |
| B cell | 11 studies | 20% ± 7% | |
| endothelial cell | 11 studies | 23% ± 5% | |
| T cell | 9 studies | 24% ± 7% | |
| CD4-positive, alpha-beta T cell | 8 studies | 21% ± 3% | |
| CD8-positive, alpha-beta T cell | 8 studies | 19% ± 4% | |
| naive B cell | 8 studies | 23% ± 5% | |
| endothelial cell of lymphatic vessel | 6 studies | 23% ± 3% | |
| monocyte | 5 studies | 19% ± 4% | |
| mature NK T cell | 5 studies | 22% ± 4% | |
| epithelial cell | 5 studies | 24% ± 13% | |
| macrophage | 5 studies | 20% ± 4% | |
| dendritic cell | 4 studies | 23% ± 6% | |
| GABAergic neuron | 4 studies | 29% ± 11% | |
| glutamatergic neuron | 4 studies | 36% ± 9% | |
| astrocyte | 4 studies | 24% ± 8% | |
| hematopoietic precursor cell | 3 studies | 33% ± 2% | |
| gamma-delta T cell | 3 studies | 32% ± 15% | |
| memory B cell | 3 studies | 21% ± 3% | |
| smooth muscle cell | 3 studies | 21% ± 3% | |
| basal cell | 3 studies | 19% ± 3% | |
| interneuron | 3 studies | 27% ± 5% | |
| oligodendrocyte | 3 studies | 26% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 22% ± 4% | |
| regulatory T cell | 3 studies | 27% ± 3% |
